Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3β on a muscle-specific promoter

Metabolism: Clinical and Experimental

Volumn 53, Issue 10, 2004, Pages 1322-1330

  Pearce, Nigel J ^a,b   Arch, Jonathan R S ^a   Clapham, John C ^a   Coghlan, Matthew P ^a   Corcoran, Stacey L ^a   Lister, Carolyn A ^a   Llano, Andrea ^a   Moore, Gary B ^a   Murphy, Gregory J ^a   Smith, Stephen A ^a   Taylor, Colleen M ^a   Yates, John W ^a   Morrison, Alastair D ^a   Harper, Alexander J ^a   Roxbee Cox, Lynne ^a   Abuin, Alejandro ^a   Wargent, Ed ^a   Holder, Julie C ^a  

^a UNIVERSITY OF BUCKINGHAM   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; GLYCOGEN; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN RECEPTOR SUBSTRATE 1; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE OVEREXPRESSION; GLUCOSE INTOLERANCE; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; SEX DIFFERENCE; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ANIMALS; BLOTTING, WESTERN; BODY COMPOSITION; BODY WEIGHT; DNA PRIMERS; DNA, COMPLEMENTARY; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; GLYCOGEN; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INSULIN RESISTANCE; LIPIDS; LIVER; MALE; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; PHENOTYPE; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 4544317872     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.05.008     Document Type: Article

References (52)

1. DeFronzo R.A., Bonadonna R.C., Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 15:1992;318-368
2. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest. 89:1992;1069-1075
3. Cohen P. Muscle glycogen synthase. Boyer P., Krebs E. The Enzymes. 1986;461-497 Academic Press, New York, NY
4. Nikoulina S.E., Ciaraldi T.P., Mudaliar S., et al. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes. 49:2000;263-271
5. Cline G.W., Petersen K.F., Krssak M., et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med. 341:1999;240-246
6. 31P NMR spectroscopy. Am J Physiol. 280:2001;E598-E607
7. Murphy E., Hellerstein M. Is in vivo nuclear magnetic resonance spectroscopy currently a quantitive method for whole-body carbohydrate metabolism? Nutr Rev. 58:2000;304-314
8. Ortmeyer H.K. In vivo insulin regulation of skeletal muscle glycogen synthase in calorie-restricted and in ad libitum-fed rhesus monkeys. J Nutr. 131:2001;907S-912S
9. Chang P.Y., Jenson J., Printz R.L., et al. Overexpression of hexokinase II in transgenic mice. J Biol Chem. 271:1996;14834-14839
10. Manchester J., Skurat A.V., Roach P., et al. Increased glycogen accumulation in transgenic mice overexpressing glycogen synthase in skeletal muscle. Proc Natl Acad Sci USA. 93:1996;10707-10711
11. Ren J.M., Marshall B.A., Mueckler M.M., et al. Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. J Clin Invest. 95:1995;429-432
12. Gibbs E.M., Stock J.L., McCoid S.C., et al. Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J Clin Invest. 95:1995;1512-1518
13. Brozinick J.T., Yaspelkis B.B., Wilson C.M., et al. Glucose transport and GLUT4 protein distribution in skeletal muscle of GLUT4 transgenic mice. Biochem J. 313:1996;133-140
14. Perriot L.M., Kono T., Whitesell R.R., et al. Glucose uptake and metabolism by cultured human skeletal muscle cells Rate limiting steps. Am J Physiol. 281:2001;E72-E80
15. Lawrence J.C., Roach P. New insights into the role and mechanism of glycogen synthase activation by insulin. Diabetes. 46:1997;541-547
16. Eldar-Finkelman H., Krebs E.G. Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc Natl Acad Sci USA. 94:1997;9660-9664
17. Welsh G.I., Wilson C., Proud C.G. GSK3 A SHAGGY frog story. Trends Cell Biol. 6:1996;274-279
18. Schmitz-Peiffer C., Whitehead J. IRS-1 regulation in health and disease. Life. 55:2003;367-374
19. Hogan B., Beddington R., Constantini F., et al. Manipulating the Mouse Embryo A Laboratory Manual. (ed 2) :1994;Cold Spring Harbor Press, Cold Spring Harbor, NY
20. Moore G.B., Himms-Hagen J., Harper M.E., et al. Overexpression of UCP-3 in skeletal muscle of mice results in increased expression of mitochondrial thioesterase mRNA. Biochem Biophys Res Commun. 283:2001;785-790
21. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254
22. Coghlan M.P., Culbert A.A., Cross D.A.E., et al. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol. 7:2000;793-803
23. Chan T.M., Exton J.H. A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepatocytes. Anal Biochem. 71:1976;96-105
24. Passonneau J.V., Lauderdale V.R. A comparison of three methods of glycogen measurement in tissues. Anal Biochem. 60:1974;405-412
25. Young P.W., Cawthorne M.A., Coyle P.J., et al. Repeat treatment of obese mice with BRL 49653, a new and potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling. Diabetes. 44:1995;1087-1092
26. Ohlsson C., Hellberg N., Parini P., et al. Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem Biophys Res Commun. 278:2000;640-645
27. Garofalo RS, Orena SJ, Schachter JB: Transgenic expression of glycogen synthase kinase 3 in muscle. Patent EP 1 321 033 A1. 2003, Europe, 6-12-2002
28. Bruning J.C., Winnay J., Bonner-Weir S., et al. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell. 88:1997;561-572
29. Kido Y., Burks D.J., Withers D., et al. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest. 105:2000;199-205
30. Thomas M.K., Devon O.N., Lee J.H., et al. Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1. J Clin Invest. 108:2001;319-329
31. Hevener A., Reichart D., Janez A., et al. Female rats do not exhibit free fatty acid-induced insulin resistance. Diabetes. 51:2002;1907-1912
32. Picton C., Aitken A., Bilham T., et al. Multisite phosphorylation of glycogen synthase from rabbit skeletal muscle. Organisation of the seven sites in the polypeptide chain. Eur J Biochem. 124:1982;37-45
33. Thorburn A.W., Gumbiner B., Bulacan F., et al. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest. 85:1990;522-529
34. Damsbo P., Vaag A., Hother-Nielsen O., et al. Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 34:1991;239-245
35. Wojtaszewski J.F.P., Hansen B.F., Gade J., et al. Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes. 49:2000;325-331
36. Kida Y., Espsito-Del Puente A., Bogardus C., et al. Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle. J Clin Invest. 85:1990;476-481
37. Saad M., Araki E., Miralpiex M. Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J Clin Invest. 90:1992;1839-1849
38. Kerouz N., Horsch D., Pons S. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest. 100:1997;3164-3172
39. Hartley D., Cooper G.M. Role of mTOR in the degradation of IRS-1 Regulation of PP2A activity. J Cell Biochem. 85:2002;304-314
40. Nikoulina S.E., Ciaraldi T.P., Mudaliar S., et al. Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle. Diabetes. 51:2002;2190-2198
41. Beck-Nielsen H., Vaag A., Damsbo P., et al. Insulin resistance in skeletal muscles in patients with NIDDM. Diabetes Care. 15:1992;418-429
42. Watts C., Malthus R.S. Liver glycogen synthase in rats with a glycogen-storage disorder The role of glycogen in the regulation glycogen synthase. Eur J Biochem. 108:1980;73-77
43. Kim J.K., Michael M.D., Previs S.F., et al. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J Clin Invest. 105:2000;1791-1797
44. Smith D.G., Buffet M., Fenwick A.E., et al. 3-Anilino-4-arylmaleimides Potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorg Med Chem Lett. 11:2001;635-639
45. Martin W.H., Hoover D.J., Armento S.J., et al. Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo. Proc Natl Acad Sci USA. 95:1998;1776-1781
46. Lochhead P.A., Coghlan M., Rice S.Q., et al. Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression. Diabetes. 50:2001;937-946
47. Cline G.W., Johnson K., Regittnig W., et al. Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes. 51:2002;2903-2910
48. Tabata I., Schluter J., Gulve E.A., et al. Lithium increases susceptibility of muscle glucose transport to stimulation by various agents. Diabetes. 43:1994;903-907
49. Henriksen E.J., Kinnick T.R., Teachey M.K., et al. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats. Am J Physiol. 284:2003;E892-E900
50. Ring B., Johnson K., Henriksen E., et al. Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes. 52:2003;588-595
51. Witherington J., Bordas V., Garland S.L., et al. 5-Aryl-pyrazolo [3,4-b]pyridines Potent inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorg Med Chem Lett. 13:2003;1577-1580
52. Witherington J., Bordas V., Haigh D., et al. 5-Aryl-pyrazolo [3,4-b]pyridazines Potent inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorg Med Chem Lett. 13:2003;1581-1584